Survival outcomes and prognostic factors in high risk locally advanced rectal cancers (LARC) undergoing concurrent capecitabine and long course radiation (Cape - RT) - results of a large cohort studyANNALS OF ONCOLOGYIF65.42023-06-010OA
Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 studyANNALS OF ONCOLOGYIF65.42022-06-010OAAI
A prospective phase 1b dose de-escalation open-label clinical study to evaluate the safety and efficacy of sorafenib with metformin and atorvastatin in advanced hepatocellular carcinoma (SMASH)ANNALS OF ONCOLOGYIF65.42021-07-010OAAI
A two arm randomized prospective superiority phase II multicentric clinical trial to evaluate the efficacy of capecitabine-irinotecan (CAPIRI) versus irinotecan in advanced gall bladder cancer progressing on first line chemotherapyANNALS OF ONCOLOGYIF65.42020-07-010OAAI
Outcomes of gastrointestinal tumours in the tyrosine kinase inhibitor era: 15 years of experience from a single tertiary care centre in IndiaANNALS OF ONCOLOGYIF65.42019-07-011OAAI
SBRT for large hepatocellular cancer unsuitable for other therapies: Results from a clinical auditRADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
Stereotactic Body Radiation Therapy Post Induction Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52018-11-010OAAI
Feasibility of Wait and Watch Approach after Neoadjuvant Chemoradiotherapy in Rectal Cancer in Low- and Middle-Income Countries: Initial Experience in Tertiary Cancer Centre in IndiaINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52018-11-010OAAI
Changes in normal liver volume after high dose radiation in cancer of the liverRADIOTHERAPY AND ONCOLOGYIF5.32017-05-010OAAI
Changes in Normal Liver Volume after Radiation in Cancer of the Liver: a Case SeriesCLINICAL ONCOLOGYIF32017-03-010PREAI